Skip to main content
. 2023 Apr 20;5(7):522–529. doi: 10.1016/j.cjco.2023.03.016

Figure 2.

Figure 2

Adverse events during follow-up, by antithrombotic strategy. DAPT, dual antiplatelet therapy; DRT, device-related thrombus; MI, myocardial infarction; OAC, oral anticoagulant; SAPT, single antiplatelet therapy; TIA, transient ischemic attack.